UP!
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q3 2022 | 2022-10-24 | Future report Set alerts | |
| Q2 2022 | 2022-08-02 | 0.35 | 0.35 |
| Q1 2022 | 2022-05-03 | 0.26 | 0.26 |
| Q4 2021 | 2022-03-01 | 0.39 | 0.39 |
| Q3 2021 | 2021-10-26 | 0.39 | 0.39 |
| Q2 2021 | 2021-07-27 | 0.31 | 0.31 |
| Q1 2021 | 2021-04-27 | 0.31 | 0.31 |
| Q4 2020 | 2021-03-02 | 0.21 | 0.21 |
| Q3 2020 | 2020-11-03 | 0.34 | 0.34 |
| Q2 2020 | 2020-07-28 | 0.40 | 0.40 |
| 2016-07-07 | Initiated Coverage | Compass Point | Neutral | $12.65 |
| 2016-05-04 | Reiterated Rating | National Securities | Buy | $14.00 |
| 2016-03-17 | Upgrade | Oppenheimer | Outperform | $14.00 |
| 2016-03-17 | Upgrade | Oppenheimer Holdings Inc. | Outperform | $14.00 |
| 2016-03-14 | Reiterated Rating | National Securities | Buy | $14.00 |
| 2016-03-10 | Upgrade | Oppenheimer | Market Perform to Outperform | |
| 2016-03-02 | Upgrade | Barrington Research | Market Perform to Outperform | $15.00 |
| 2016-01-27 | Downgrade | Raymond James | Outperform to Market Perform | |
| 2016-01-27 | Downgrade | Raymond James Financial Inc. | Outperform to Market Perform | |
| 2015-11-12 | Reiterated Rating | Ladenburg Thalmann | Buy | $13.50 |
| 2015-11-10 | Upgrade | Raymond James | Market Perform to Outperform | $12.00 |
| 2015-11-04 | Reiterated Rating | National Securities | Buy | $14.00 |
| 2015-10-08 | Reiterated Rating | National Securities | Buy | $14.00 |
| 2015-08-06 | Lower Price Target | Keefe, Bruyette & Woods | $14.00 to $12.50 | |
| 2015-08-05 | Reiterated Rating | National Securities | Buy | $14.00 |
| 2015-07-24 | Reiterated Rating | Keefe, Bruyette & Woods | Market Perform | |
| 2015-07-24 | Upgrade | National Securities | Neutral to Buy | $14.00 |
| 2015-07-10 | Reiterated Rating | National Securities | Neutral | $14.00 |
| 2015-07-02 | Boost Price Target | Gilford Securities | $14.25 | |
| 2015-07-01 | Upgrade | Gilford Securities | Neutral to Buy | |
| 2015-06-04 | Lower Price Target | National Securities | Neutral | $15.00 to $14.00 |
| 2015-06-04 | Downgrade | Oppenheimer | Outperform to Market Perform | |
| 2015-05-26 | Initiated Coverage | National Securities | Neutral | $15.00 |
| 2015-05-13 | Initiated Coverage | Oppenheimer | Positive to Outperform | $15.00 |
| 2015-03-12 | Upgrade | Wunderlich | Hold to Buy | $14.50 to $15.00 |
| 2014-08-06 | Upgrade | Raymond James | Underperform to Market Perform | |
| 2014-08-06 | Upgrade | Keefe, Bruyette & Woods | Underperform to Market Perform | |
| 2014-07-28 | Downgrade | Wunderlich | Buy to Hold | $15.00 to $14.50 |
| 2014-06-27 | Downgrade | National Securities | Buy to Neutral | $15.00 |
| 2014-06-19 | Boost Price Target | Keefe, Bruyette & Woods | $13.00 to $14.00 | |
| 2014-06-18 | Reiterated Rating | FIG Partners | Neutral | |
| 2014-05-13 | Downgrade | Gilford Securities | Buy to Neutral | |
| 2014-03-13 | Lower Price Target | Maxim Group | Buy | $17.00 to $14.50 |
| 2014-03-13 | Reiterated Rating | National Securities | Buy | $15.00 |
| 2014-03-13 | Boost Price Target | Guggenheim | $14.00 | |
| 2014-03-12 | Downgrade | Gilford Securities | Market Perform to Underperform | $13.00 |
| 2014-03-12 | Downgrade | Keefe, Bruyette & Woods | Market Perform to Underperform | $14.75 to $13.00 |
| 2013-12-20 | Initiated Coverage | Guggenheim | Buy | |
| 2013-12-09 | Initiated Coverage | National Securities | Buy | $16.00 |
| 2013-11-05 | Initiated Coverage | JMP Securities | Market Perform | |
| 2013-04-18 | Upgrade | Gilford Securities | Hold to Buy | |
| 2013-03-01 | Initiated | Wunderlich | Buy | $16.50 |
| 2013-01-15 | Initiated | Maxim Group | Buy | $17.50 |
| 2012-11-09 | Upgrade | Gildford Securities | Hold to Buy | |
| 2012-02-03 | Downgrade | Stifel Nicolaus | Buy to Hold | |
| 2011-02-10 | Initiated | Northland Securities | Outperform | $18 |
| 2016-07-07 | Initiated Coverage | Compass Point | Neutral | $12.65 |
| 2016-05-04 | Reiterated Rating | National Securities | Buy | $14.00 |
| 2016-03-17 | Upgrade | Oppenheimer | Outperform | $14.00 |
| 2016-03-17 | Upgrade | Oppenheimer Holdings Inc. | Outperform | $14.00 |
| 2016-03-14 | Reiterated Rating | National Securities | Buy | $14.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In HRZN 38 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| SHELTON CAPITAL MANAGEMENT | 0.39M |
| Advisors Asset Management, Inc. | 0.27M |
| TWO SIGMA ADVISERS, LLC | 0.24M |
| Eqis Capital Management, Inc. | 0.18M |
| BlackRock Inc. | 0.14M |
| Marshall Wace LLP | 0.13M |
| CITADEL ADVISORS LLC | 0.11M |
| TWO SIGMA INVESTMENTS LLC | 87921 |
| MORGAN STANLEY | 55421 |
| NGAM ADVISORS, L.P. | 53418 |
| Invesco Ltd. | 53000 |
| MACKENZIE FINANCIAL CORP | 42989 |
| ROYAL BANK OF CANADA | 38000 |
| PATHSTONE FAMILY OFFICE, LLC | 31380 |
| WFG Advisors, LP | 24950 |
UM